Analytical and Bioanalytical Chemistry

, Volume 408, Issue 26, pp 7255–7264

Biosensors for liquid biopsy: circulating nucleic acids to diagnose and treat cancer

Part of the following topical collections:
  1. Chemical Sensing Systems


The detection of cancer biomarkers freely circulating in blood offers new opportunities for cancer early diagnosis, patient follow-up, and therapy efficacy assessment based on liquid biopsy. In particular, circulating cell-free nucleic acids released from tumor cells have recently attracted great attention also because they become detectable in blood before the appearance of other circulating biomarkers, such as circulating tumor cells. The detection of circulating nucleic acids poses several technical challenges that arise from their low concentration and relatively small size. Here, possibilities offered by innovative biosensing approaches for the detection of circulating DNA in peripheral blood and blood-derived products such as plasma and serum blood are discussed. Different transduction principles are used to detect circulating DNAs and great advantages are derived from the combined use of nanostructured materials.


Biosensor DNA Electrochemistry Surface plasmon resonance Liquid biopsy 

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  1. 1.Consorzio Interuniversitario di Ricerca in Chimica dei Metalli nei Sistemi Biologici, c/o Dipartimento di Scienze ChimicheUniversità di CataniaCataniaItaly
  2. 2.Dipartimento di Scienze ChimicheUniversità di CataniaCataniaItaly
  3. 3.Consorzio Interuniversitario Istituto Nazionale Biostrutture e Biosistemi, c/o Dipartimento di Scienze ChimicheUniversità di CataniaCataniaItaly

Personalised recommendations